Zhejiang Xinguang Pharmaceutical Co., Ltd. (SHE:300519)
China flag China · Delayed Price · Currency is CNY
15.03
+1.22 (8.83%)
Oct 23, 2026, 3:04 PM CST

SHE:300519 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
270.47265.13267.54270.28351.37320.77
Other Revenue
0.230.230.120.110.120.11
270.7265.36267.66270.4351.49320.88
Revenue Growth
5.30%-0.86%-1.01%-23.07%9.54%13.35%
Cost of Revenue
142.84163.14177.89160.03169.81145.29
Gross Profit
127.86102.2289.77110.37181.68175.58
Selling, General & Admin
35.2538.2641.543.6450.6149.27
Research & Development
1313.3512.6215.1315.5513.52
Other Operating Expenses
6.224.353.53.434.264.22
Operating Expenses
54.2355.7657.7461.5170.8666.85
Operating Income
73.6246.4632.0348.87110.82108.73
Interest & Investment Income
6.9916.7623.5522.9814.0923.03
Other Non Operating Income (Expenses)
-0.1-0.01-0.01-0.02-0.01-0.01
EBT Excluding Unusual Items
80.5263.255.5771.83124.9131.74
Gain (Loss) on Sale of Assets
0.13-0-0.07-0.29--0.71
Asset Writedown
0.15-0.04-0.010.020-0.02
Other Unusual Items
2.820.271.511.60.70.95
Pretax Income
83.6263.4357.0173.16125.6131.96
Income Tax Expense
10.649.226.628.816.7817.68
Net Income
72.9854.2150.3964.36108.82114.28
Net Income to Common
72.9854.2150.3964.36108.82114.28
Net Income Growth
25.94%7.58%-21.70%-40.86%-4.78%15.46%
Shares Outstanding (Basic)
158159163161160161
Shares Outstanding (Diluted)
158159163161160161
Shares Change
-4.65%-1.91%1.03%0.54%-0.58%0.83%
EPS (Basic)
0.460.340.310.400.680.71
EPS (Diluted)
0.460.340.310.400.680.71
EPS Growth
32.09%9.68%-22.50%-41.18%-4.23%14.52%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
92.1465.4548.2337.3109.78127.64
Free Cash Flow Per Share
0.580.410.300.230.690.79
Dividend Per Share
0.3000.3000.3000.4000.5000.600
Dividend Growth
0%0%-25.00%-20.00%-16.67%0%
Gross Margin
47.23%38.52%33.54%40.82%51.69%54.72%
Operating Margin
27.20%17.51%11.97%18.07%31.53%33.88%
Profit Margin
26.96%20.43%18.83%23.80%30.96%35.62%
Free Cash Flow Margin
34.04%24.66%18.02%13.80%31.23%39.78%
EBITDA
88.2161.246.9763.64124.88121.59
EBITDA Margin
32.59%23.06%17.55%23.54%35.53%37.89%
D&A For EBITDA
14.5914.7414.9314.7714.0512.86
EBIT
73.6246.4632.0348.87110.82108.73
EBIT Margin
27.20%17.51%11.97%18.07%31.53%33.88%
Effective Tax Rate
12.73%14.53%11.61%12.03%13.36%13.40%
Revenue as Reported
59.74265.36267.66270.4351.49320.88